In vitro comparative evaluation of trastuzumab (Herceptin®) combined with paclitaxel (Taxol®) or docetaxel (Taxotere®) in HER2-expressing human breast cancer cell linesJean‐Louis Merlin, Nicolas Bachmann|Annals of Oncology|2002Cited by 82